Human immunodeficiency virus (HIV) DNA load and level of immunosuppression in treatment-naive HIV-1 infected patients

被引：16

作者：

Riva, E

Antonelli, G

Scagnolari, C

Pistello, M

Capobianchi, MR

Monforte, AD

Pezzotti, P

Dianzani, F

机构：

[1] Univ Roma La Sapienza, Virol Lab, Rome, Italy

[2] Univ Roma La Sapienza, Dept Expt Med & Pathol, Virol Sect, I-00185 Rome, Italy

[3] L Spallanzani Hosp Infect Dis, Ist Ricovero & Cura Carattere Sci, Rome, Italy

[4] Ist Super Sanita, Ctr Operat AIDs, I-00161 Rome, Italy

[5] Univ Pisa, Ctr Retrovirus, Pisa, Italy

[6] Univ Milan, Inst Infect Dis & Trop Med, L Sacco Hosp, Milan, Italy

来源：

JOURNAL OF INFECTIOUS DISEASES | 2003年 / 187卷 / 11期

关键词：

D O I：

10.1086/375251

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1826 / 1828

页数：3

共 8 条

[1]

[Anonymous], 2001, STAT STAT SOFTW REL

[2] Relationship between the size of the human immunodeficiency virus type 1 (HIV-1) reservoir in peripheral blood CD4+ T cells and CD4+:CD8+ T cell ratios in aviremic HIV-1-Infected individuals receiving long-term highly active antiretroviral therapy [J].

Chun, TW ;

Justement, JS ;

Pandya, P ;

Hallahan, CW ;

McLaughlin, M ;

Liu, SY ;

Ehler, LA ;

Kovacs, C ;

Fauci, AS .

JOURNAL OF INFECTIOUS DISEASES, 2002, 185 (11) :1672-1676

[3] Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy [J].

Furtado, MR ;

Callaway, DS ;

Phair, JP ;

Kunstman, KJ ;

Stanton, JL ;

Macken, CA ;

Perelson, AS ;

Wolinsky, SM .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (21) :1614-1622

[4] Quantitation of human immunodeficiency virus type 1 DNA forms with the second template switch in peripheral blood cells predicts disease progression independently of plasma RNA load [J].

Kostrikis, LG ;

Touloumi, G ;

Karanicolas, R ;

Pantazis, N ;

Anastassopoulou, C ;

Karafoulidou, A ;

Goedert, JJ ;

Hatzakis, A .

JOURNAL OF VIROLOGY, 2002, 76 (20) :10099-10108

[5] HIV-1 replication in patients with undetectable plasma virus receiving HEART [J].

Natarajan, V ;

Bosche, M ;

Metcalf, JA ;

Ward, DJ ;

Lane, HC ;

Kovacs, JA .

LANCET, 1999, 353 (9147) :119-120

[6] Decay of HIV type 1 DNA and development of drug-resistant mutants in patients with primary HIV type 1 infection receiving highly active antiretroviral therapy [J].

Riva, E ;

Pistello, M ;

Narciso, P ;

D'Offizi, G ;

Isola, P ;

Galati, V ;

Turriziani, O ;

Tozzi, V ;

Vincenzi, L ;

Dianzani, F ;

Antonelli, G .

AIDS RESEARCH AND HUMAN RETROVIRUSES, 2001, 17 (17) :1599-1604

[7] Prognostic value of baseline human immunodeficiency virus type 1 DNA measurement for disease progression in patients receiving nucleoside therapy [J].

Tierney, C ;

Lathey, JL ;

Christopherson, C ;

Bettendorf, DM ;

D'Aquila, RT ;

Hammer, SM ;

Katzenstein, DA .

JOURNAL OF INFECTIOUS DISEASES, 2003, 187 (01) :144-148

[8]

Wong JK, 1997, SCIENCE, V278, P1295

← 1 →